Digital Mammography
Proprietary technology for early diagnosis
Fujifilm was the first to receive U.S. Food and Drug Administration (FDA) PMA approval for computed radiography in mammography. With over 6,000 units installed, the FCR PROFECT CS/ONE has earned the acclaim and trust of healthcare institutions worldwide. The launch of the AMULET DR mammography system, featuring new direct-conversion FPD, further underlines Fujifilm's commitment to providing the best solutions to support women's health.
Products
Patented direct conversion flat panel detector technology for 50-micrometer imaging precision.
The high-throughput FCR reader capable of precise 50µm resolution for mammography with a dual-side reading.
High-resolution one-stacker FCR reader capable of 50µm resolution for mammography with a double-side reading.
FCR CAPSULA XLII equipped with the optional capability of 50-micron reading with the HR-V can visualize more fine and minute structures. It is suited for mammography applications.
For all women. Finer viewing detail and enhanced ease of use. Optimized workflow and imaging
Mammo console for PROFECT.
Computer aided detection (CAD) system analyzes images to help detect breast cancer.
A dedicated quality control program for Fujifilm digital mammography systems to support stable image quality in screening and diagnosis.
Related Products
- Dry Imager
- Film and Screen
Read more about our products in these downloadable PDF format brochures.
Related Links
Image Intelligence™
About Fujifilm's advanced image processing technology.
Pink ribbon campaigns
Fujifilm supports campaigns to promote breast cancer screening.
- Products
- Consumer Products
- Business Products
- Support
- Digital Cameras and Printers
- Sustainability
- About Us
Fujifilm Corporation is a wholly-owned subsidiary of Fujifilm Holdings Corporation.